SureTrader SureTrader SureTrader
Home > Boards > US OTC > Miscellaneous >

EP Global Communications, Inc. (EPGL)

EPGL RSS Feed
Add EPGL Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, flaflyersfan, integral, Stock Barber
Search This Board:
Last Post: 1/19/2017 9:42:17 PM - Followers: 476 - Board type: Free - Posts Today: 0

 

                         


About the Company:

EP Global Communications, Inc. is an Advanced Technology Research and Development company for both Medical Devices and Consumer Electronics Devices specializing in Microelectronic Mechanical Systems (MEMS). For more information about the company, please click on the banner above to be directed to the comapny website.

People, Products & Process:
EPGL has assembled an impressive team to propel the company into a bright future and to build shareholder value. Under the leadership of Michael Hayes EPGL underwent debt restructuring, assembly of a new management team, as well as medical and scientific personnel. Mr. Hayes has made it a singular priority to bring aboard only the world’s top professionals in the field of medical sciences to EPGL and thereby build the Company into a major player in the Medical Device Industry over the next several years. He has also committed to prioritizing shareholders and creating significant value for their investment over time. We have seen great evidence of the har work over the last couple years as EPGL has signed Development Agreements with CooperVision, Intel, and AT&T. EPGL is in negotiations to licence technology to CooperVision presently. On April 28th 2015, EPGL disclosed to shareholders that
EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties. Shareholders can expect developments on this in the near future.


One key team member that was brought on board is David Markus (Vice President, BioMEMS) Developer, As you will see David Markus is a Well Accomplished Engineer.

David T. Markus holds a Ph.D. in Biomedical Engineering and a MS in Electrical Engineering with an emphasis in MEMS Microelectronics and Biomedical. Dr. Markus spent 11 years with Raytheon and holds 8 US patents and has 9 other US Patents Pending. He has been involved in research for several of the world's leading technological institutions, including the Office of Naval Research in Arlington, Virginia, NASA Jet Propulsion Laboratory in Pasadena, CA and he has been published 15 times for various technical conferences. He was a principal investigator on SBIR DARPA Phase I and Phase II, and "Ultraflexible Substrate" for Macroelectronics Program by Dr. Robert Reuss at DARPA. He has been involved in the engineering and the development on seven surgical devices, including devices for Cataract surgery, Intra-Ocular Lens Delivery, Arthroscopy, Endodontic Endoscope, Micro Endoscope and Neural Electrodes. Additionally he was instrumental on developing three medical laboratory devices, including for In-Vitro Fertilization, PCR instrumentation and drug discovery.

The Company has significant know-how and Intellectual Property in the arena of BioMEMS and has invented new device technologies which include, but are not limited to the following:
 
1. Advanced Power Source for Contact Lenses 11. Advanced TopSpin Platform Technology for Development of Smart Medical Devices
2. Advanced Cell Regeneration Technology to Treat Eye Disease 12. Advanced Device for Steam Cell Treatment Delivery
3. Advanced Cell Regeneration Technology to Treat Hearing Loss 13. Advanced Device for Treatment of Prostate Tumors
4. Advanced Nerve Ablation Device 14. Advanced Endoscopic Device
5. Advanced Epidural Device 15. Advanced Device for Delievery of Micron Sized Drug Payloads
6. New & Promsing Treatment of Restinitis Pigmentosa 16. New & Promising Device for Treatment of Macular Degeneration
7. Advanced Ablation Device for Nerve Treatment of Facial Glabballar Frownig 17. New Advanced Contact Lens Device
8. New Advanced PowerSource for TopSpin Medical Devices 18. Advanced Device For Delivery of Micro Mechanical Devices Into Body
9. Advanced Trigger Point Needle Device 19.  Device for  Advanced Biopsy
10. Advanced Micron Resolution Motor for Smart Medical Devices 20. Real-Time Sensor Technologies for Connectivity to a Global Network  **NEW
21.Real-Time Data Applications for Athletic Teams, Workforces and Military Forces*NEW
 
EPGL develops advanced technololgies and in negotiations currently to license them to medical device companies and consumer electronic companies.

Contract with CooperVision:
EPGL and CooperVision, Inc. (CooperVision) have signed an exclusive Development Agreement for Advanced Ophthalmic and Medical Technologies. CooperVision is a market leader in the manufacturing and marketing of contact lenses. The Cooper Companies recently completed the acquisition of Sauflon Pharmaceuticals Limited for approximately $1.2 Billion Dollars.

Material Disclosure to Shareholdrs EPGL MED JOINT PATENT VALIDATION
(Includes EPGL MED, COOPERVISION, David T.Markus, Aurthur Back, Luke A.Kilyk, Michael Hayes)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=141220
 

Exclusive Development Agreement Signed with CooperVision, Inc., a Division of The Cooper Companies, Inc. (COO, NYSE)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=125904



Contract with Intel:
On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an Initial Agreement. Additional Agreements are now pending. EPGL management believes that a relationship with Intel will be advantageous to shareholders as the two companies have synergistic goals in various fields. Details of further Agreements will be available upon mutual decision of the parties to disclose them publicly.

On September 24, 2014, EP Global Communications, Inc. (EPGL) and Intel Corporation (Intel) executed an initial Agreement. Additional Agreements are now pending.
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=127990
 


Contract with AT&T: 
A new Development Agreement has been executed between AT&T and EPGL on January 4, 2015. As a result of this agreeement Joint Intellectual Properties are now being developed certain data streaming projects in mind. EPGL continues to create new and innovative technologies with large companies
New** EPGL and AT&T have created joint Intellectual Properties and are now in the process of procuring those properties (4/28/15)
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=136848

EPGL and AT&T Developing Joint Intellectual Properties Companies Sign Development Agreement Resulting in New Inventions in IoT Data Streaming Space
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=133983

EPGL and AT&T Sign Development Agreement
https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=132040



About EPGL Medical Science's Share Structure :

EPGL has a share structure of 5 billion authorized shares with approximately 4.5 billion shares restricted and a float of approximately 499 million. Following a very successful Reverse Split EPGL has decreased the float by 90% and increased share holder value by over 500% since that time. The company has strongly stated many times that they will not sell shares into the retail market. They are here to build a real company and implement real growth. Since restructuring EPGL has not increased the Float/OS/AS and have given us there word on countless occasions they will not do so.

Pricewaterhouse Coopers, Corporate Finance and Recovery (Cayman) Ltd.Controlling Agent for:
AJW Qualified Partners, LLC, Controlled by PwC (PricewaterhouseCoopers) Worlds Largest Accounting Firm
1.975 Billion Common Shares
Mr. Michael Hayes
1.975 Billion Common Shares
FLOAT/TRADABLE SHARES : 499 Million ***Unchanged since Restructure in 2012***
Total number of shareholders of record 700 approximate 

ISSUERS FACILITIES
The Company claims to have leases or utilizes facilities in the following locations

Various California Bay Area Research Facilities Under NDA, David T. Markus, Ph.D.

Irvine, California – Research Facilities, Office

New York University Langone Medical Center, Corey W. Hunter M.D. / Eric Lee M.D.

University of Minnesota, David T. Markus, Ph.D.

University of California at Irvine, David T. Markus, Ph.D.

Dallas and Plano Texas, David T. Markus, Ph.D. **NEW**




Additional Information :
Letter From PricewaterhouseCoopers (Ian Stokoe) Congratulating EPGL on First  Devlopment Agreement (CooperVision)


Follow EPGL on the WEB at http://www.epglmed.com
http://www.epglmed.com/twitter.html






 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EPGL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#108787  Sticky Note EPGL Wins Allowance on First Patent vikingzskillz 08/30/16 10:08:17 PM
#95482  Sticky Note Press releases or other company communication should not IH Brian (Retired) 01/12/16 12:14:18 PM
#114503   That's pretty much all of California, isn't it? wobblenuts 01/19/17 09:42:17 PM
#114502   Let's all see more upward movement! allegiant 01/19/17 08:35:07 PM
#114501   EPGL is in Irvine. Many miles from San skorz 01/19/17 07:25:27 PM
#114500   Doubledown22, EPGL leaving pinksheets would require the company flaflyersfan 01/19/17 04:33:44 PM
#114499   EPGL is near San Diego, I think. wobblenuts 01/19/17 04:25:32 PM
#114498   Time for the continued accumulation and the taking H8ster 01/19/17 04:20:01 PM
#114497   EPGL is in LA LA land. AJCash 01/19/17 04:12:17 PM
#114496   Maybe JNJ is going to distribute, inWith manufactures, mfefree 01/19/17 04:10:22 PM
#114493   That's not true. For a new company to kura 01/19/17 04:01:11 PM
#114492   read the filings. Atlanta1 01/19/17 03:57:40 PM
#114491   We knew it was gonna have a lull gman22 01/19/17 03:55:00 PM
#114490   the trust is growing???????? where, looks like the KBing617 01/19/17 03:53:53 PM
#114489   producing is the problem, they are all talk, KBing617 01/19/17 03:53:07 PM
#114488   Nobody said that stuffs. That's not true. Do kura 01/19/17 03:51:28 PM
#114487   Quote EPGL says a lot of things none of kura 01/19/17 03:50:00 PM
#114486   If only you saw the reports given to H8ster 01/19/17 03:31:57 PM
#114485   EPGL says a lot of things none of KBing617 01/19/17 03:27:54 PM
#114484   nope they can't uplift without proper financials just KBing617 01/19/17 03:22:09 PM
#114483   righhttttttt, epgl!! is now the time to buy?? KBing617 01/19/17 03:19:11 PM
#114482   I don't think they can uplist without proper Atlanta1 01/19/17 03:05:48 PM
#114481   Yes. A FEW YEARS BACK! Much H8ster 01/19/17 02:56:00 PM
#114480   I really hope we will know more details franck92 01/19/17 02:55:37 PM
#114479   Problem with Pink market is the fact it franck92 01/19/17 02:48:05 PM
#114477   Epgl said they would uplist few year back kura 01/19/17 02:46:58 PM
#114475   I hope you are right. But, still that kura 01/19/17 02:38:35 PM
#114474   EPGL has zero intentions of uplisting anytime soon. H8ster 01/19/17 02:35:53 PM
#114473   In with will be a private company based kura 01/19/17 02:34:27 PM
#114472   I agree if there is no buyer but franck92 01/19/17 02:30:42 PM
#114471   I disagree with that response. Many folks told kura 01/19/17 02:26:56 PM
#114470   I am totally agree with you, I asked franck92 01/19/17 02:16:32 PM
#114469   InWith Corp the answer $EPGL vikingzskillz 01/19/17 02:15:13 PM
#114468   Folks who said pink sheet was fine giving kura 01/19/17 02:11:37 PM
#114467   No more losers to pay .03??? nowy257 01/19/17 02:10:20 PM
#114466   Bid now at .025 and strongly supported. Gonna Doubledown22 01/19/17 01:41:04 PM
#114465   Can't wait to get EPGL interests off of Doubledown22 01/19/17 01:33:23 PM
#114464   Growing patent base will enable major deals, enabling vikingzskillz 01/19/17 12:57:07 PM
#114462   Stable of patents keeps growing MAJOR Effect on vikingzskillz 01/19/17 12:54:56 PM
#114461   vikingzskillz, and once again to have little effect flaflyersfan 01/19/17 12:53:00 PM
#114460   Could $EPGL 3rd US Patent allowance be imminent? vikingzskillz 01/19/17 11:59:43 AM
#114459   It's true that there are many ways to gr8f1 01/19/17 11:58:55 AM
#114457   Only time will tell. They are inventing Valiant 01/19/17 11:51:38 AM
#114456   ..and none of them are career carrot-farming hucksters. Atlanta1 01/19/17 11:49:34 AM
#114455   Jobs = homestead high school Wozniak = Colorado & Valiant 01/19/17 11:43:14 AM
#114454   MIT Money in unique Technology franck92 01/19/17 11:42:03 AM
#114453   MIT Men in Trees (TV show) Atlanta1 01/19/17 11:40:07 AM
#114452   So Hayes went to MIT??? skorz 01/19/17 11:36:54 AM
#114451   So we're all they when they started. Valiant 01/19/17 11:33:16 AM
#114450   ROFLMFAO totally irrelevant. Atlanta1 01/19/17 11:31:35 AM
#114449   Sounds like Wozniak and Jobs when they started Valiant 01/19/17 11:28:36 AM
#114448   What's the status on this? "PIEZOELECTRIC SENSOR FOR wobblenuts 01/19/17 11:27:32 AM
PostSubject